NIDAN LABS AND HEALTH LTD Intrinsic Value
NIDAN · Healthcare · Current price ₹13.15
Is NIDAN LABS AND HEALTH LTD undervalued?
DocStoX estimates the fair value of NIDAN LABS AND HEALTH LTD at ₹59 per share, versus the current market price of ₹13. That puts the stock about +348.7% below our fair-value estimate, which we read as "Buy". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 3 independent methods: Residual income (₹45), Relative P/E (₹97), Graham floor (₹41). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹41 (bear) to ₹59 (base) to ₹97 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
Margin of safety
Value investors demand a margin of safety — a discount to intrinsic value that protects against being wrong. At ₹13 versus an intrinsic value of ₹59, NIDAN LABS AND HEALTH LTD currently offers +348.7% of margin.
More on NIDAN LABS AND HEALTH LTD
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.